AIM
ADPT icon

Arcadia Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

Arcadia Investment Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,000
Closed -$3.62K – 255
2024
Q2 		$3.62K Hold
1,000
– – ﹤0.01% 291
2024
Q1 		$3.21K Hold
1,000
– – ﹤0.01% 295
2023
Q4 		$4.9K Hold
1,000
– – ﹤0.01% 296
2023
Q3 		$5.45K Hold
1,000
– – ﹤0.01% 304
2023
Q2 		$6.71K Hold
1,000
– – ﹤0.01% 315
2023
Q1 		$8.83K Hold
1,000
– – ﹤0.01% 315
2022
Q4 		$7.64K Hold
1,000
– – ﹤0.01% 323
2022
Q3 		$7K Buy
+1,000
New +$9.42K ﹤0.01% 257

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Arcadia Investment Management's ADPT Position: Q3 2024 in Review

Arcadia Investment Management sold out of Adaptive Biotechnologies (ADPT) in Q3 2024, closing a stake of 1,000 shares — an estimated $3.62K sold.

Arcadia Investment Management first reported a position in ADPT in Q3 2022 and held it in 8 quarters. The position peaked at $8.83K in Q1 2023. 187 funds tracked by Wall St. Rank hold ADPT as of Q3 2024.

  • Arcadia Investment Management reported no remaining Adaptive Biotechnologies position as of Q3 2024 after selling out during the quarter.
  • Arcadia Investment Management sold 1,000 Adaptive Biotechnologies shares in Q3 2024, an estimated $3.62K.
  • Arcadia Investment Management first reported a position in Adaptive Biotechnologies in Q3 2022 and held it in 8 quarters.
  • Arcadia Investment Management's Adaptive Biotechnologies position peaked at $8.83K in Q1 2023.
  • 187 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2024.

Based on Arcadia Investment Management's 13F filing for Q3 2024, filed 29 Oct 2024.